Everest Medicines Acquires Exclusive Rights to VIS-101 for Serious Eye Disorders Everest Medicines announced an exclusive license with Visara, Inc. to develop, manufacture, and commerciali…
Transparent Squid for Brain Research Researchers at the Marine Biological Laboratory (MBL) in Woods Hole, Massachusetts, have successfully…
AGCO Power Unveils Next-Generation Sustainable Powertrain Innovations At Agritechnica 2025 in Hanover, AGCO Power will unveil a bold visio…
A Time for Burning: A Timeless Look at Racial Reconciliation The documentary "A Time for Burning" offered an honest look at race in 1960s …
Anti-VEGF Innovations in Retinal Disease Emerging anti-VEGF agents offer enhanced durability and anatomic outcomes in retinal disease.…
Wizz Air Revives $580 Pass and Tests Business Class Wizz Air brings back its $580 'All You Can Fly' deal and begins testing a new business…
INDIA at TCT 2025: TUXEDO-2 Trial The TUXEDO-2 trial, led by Dr. Upendra Kaul, compares next-generation drug-eluting stents in diabetic pa…
2025 Proton eMAS 5 Launched in Malaysia The 2025 Proton eMAS 5 has been launched in Malaysia as the national carmaker's second fully-elect…
VALANX Biotech Appoints New Chief Scientific Officer VALANX Biotech, a biotech company, has appointed Klaus Orlinger, PhD, as its new Chie…
Hong Kong Tennis Open: Last China Players Exit China's last two representatives, Zhang Shuai and Wang Yafan, lost in straight sets at the …
Hong Kong's Securities Watchdog Eyes IPO Reform Hong Kong's market regulator is reviewing rules to potentially allow smaller but high-pote…